Hca Healthcare Inc Stock Price, News & Analysis

HCA Healthcare (NYSE:HCA) announced a $1.5 million grant from the HCA Healthcare Foundation Healthier Tomorrow Fund to support March of Dimes' Low Dose, Big Benefits campaign, focused on preventing preeclampsia and improving maternal and infant health.

The campaign targets provider education, patient and community awareness, and quality improvement in Federally Qualified Health Centers in Houston, TX and Miami, FL. Preeclampsia affects 1 in 8 pregnancies and one brief cited only 11% of eligible high-risk patients were prescribed low-dose aspirin. HCA cites shared programs, clinical collaborations, and curated data from >200,000 annual deliveries to support implementation and measurement.

HCA Healthcare (NYSE: HCA) will present at two investor conferences in November 2025: the UBS Global Healthcare Conference on November 12, 2025 at 9:30 AM ET and the Wolfe Research Healthcare Conference on November 17, 2025 at 12:00 PM ET.

A live audio webcast link and any presentation materials will be posted in the Investor Relations section of the company website at www.hcahealthcare.com. Dates and times may change; check the conference schedule or investor site for updates.

HCA (NYSE: HCA) announced that its subsidiary HCA Inc. proposes a public offering of senior notes on October 27, 2025, subject to market conditions.

Actual maturity, interest rate and principal amount will be set at pricing. HCA Inc. said net proceeds are intended for general corporate purposes, which may include repayment of borrowings under its $4.000 billion commercial paper program and may be used to redeem all or part of the $1.500 billion aggregate principal of its 5.875% senior notes due 2026.

J.P. Morgan, Citigroup, Mizuho and Wells Fargo are joint book‑running managers; the offering is on an effective shelf registration and available via a preliminary prospectus supplement.

HCA Healthcare (NYSE: HCA) reported 3Q 2025 results: revenues $19.161B (+9.6%), net income $1.643B (+29.4%), and EPS $6.96 (+42.6%). Adjusted EBITDA $3.870B (+18.5%). Same-facility admissions rose ~2.1% and revenue per equivalent admission +6.6%.

The company repurchased 6.514M shares for $2.498B, has $3.256B remaining buyback authorization, declared a $0.72 quarterly dividend, and ended 3Q with $997M cash and $44.511B total debt. Capital expenditures year estimate ~$5.0B.

Management raised 2025 guidance: revenues $75.0–76.5B, net income $6.495–6.715B, Adjusted EBITDA $15.25–15.65B, and EPS $27.00–28.00.

HCA Healthcare (NYSE:HCA) will host its seventh annual “Crush the Crisis” national prescription drug take back day on Oct. 25, 2025, with more than 140 collection sites partnering with local law enforcement for anonymous disposal of unused or expired medications.

HCA has helped dispose of >88,000 pounds since 2019 and aims to reach 100,000 pounds. The company cites a nearly 27% drop in national drug overdose deaths in 2024 and highlights clinical programs—Enhanced Surgical Recovery (ESR) and Electronic Prescribing of Controlled Substances (EPCS)—and its ~44 million annual patient encounters supporting prevention and safer prescribing.

HCA Healthcare (NYSE:HCA) announced its 2025 Awards of Distinction recipients, recognizing outstanding employees, physicians, and volunteers. The awards include the Frist Humanitarian Award and the Excellence in Nursing Award, representing the highest honors within the organization.

The Frist Humanitarian Award recipients include Rachel Cantarero from HCA Houston, Dr. Mohammad Subeh from Good Samaritan Hospital, and Kathy Ward from West Valley Medical Center. Each employee and volunteer recipient receives $10,000 plus $10,000 for charity, while physician recipients receive $20,000 for charity.

The Excellence in Nursing Award winners are Susan Roberts-Bradley for Professional Mentoring and Max Fransen for Compassionate Care, each receiving $10,000 plus $10,000 for charity.

HCA Healthcare (NYSE:HCA) has scheduled its third quarter 2025 earnings conference call for October 24, 2025, at 10:00 AM Eastern Time. The healthcare provider will host a live audio webcast accessible through their investor relations website.

Investors and analysts can participate in the earnings call to discuss HCA's financial performance for Q3 2025. For those unable to attend the live event, an archived version will be available on the company's website.

HCA Healthcare (NYSE:HCA) and its Foundation announced a continued collaboration with the American Heart Association through $3.9 million in funding for the Getting to the Heart of Stroke™ initiative. The program has achieved significant results since 2022, reaching over 200 million individuals with AFib and stroke risk education and expanding to more than 160 community organizations.

Key achievements include a 33% improvement in stroke cause identification at participating hospitals through enhanced care team collaboration. HCA Healthcare will expand its quality improvement efforts to all 43 comprehensive stroke centers, focusing on preventing stroke-related disability and implementing evidence-based practices.

HCA Healthcare (NYSE:HCA) has announced its participation in the upcoming Wells Fargo 2025 Healthcare Conference. The company's presentation is scheduled for September 4, 2025, at 2:15 PM ET.

Interested parties can access the live audio webcast and related presentation materials through HCA Healthcare's Investor Relations website at www.hcahealthcare.com. The company notes that presentation timing may be subject to change and recommends checking the conference schedule or company website for the most current information.